Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious
A comparative study of the behaviour of left-sided infective endocarditis (left-sided IE) due to Streptococcus agalactiae (GBS) with left-sided IE caused by Staphylococcus aureus (SA). A prospective, multicentre cohort study in eight public hospitals in Spain, from January 1984 to December 2015; comparative analysis and factors associated with mortality. In total, there were 1754 episodes of left-sided IE; 41 (2.3%) caused by GBS vs. 344 (19.6%) due to SA, definitive IE 39 vs. 324 cases, males, 25 vs. 213, respectively. There were no differences in age or comorbidity, and healthcare-associated acquirement was 10% vs. 43%, p 0.001. Transthoracic echocardiogram (TTE) was performed in 95% vs. 96.8% and a transesophageal echocardiogram (TEE) in 61% vs. 56%. Vegetations were detected in 80% and measured > 1 cm in a similar proportion. It affected native valves in 85.4% vs. 82.6% and late prosthetic valve in 14.6% vs. 9.6%. The course was acute in both groups. There were more skin manifestations in SA left-sided IE, 7.3% vs. 32%, p 0.001. Both groups had similar complications, but in SA, there was more renal failure, 24% vs. 45%, p 0.010. Surgical risk and operated patients were similar. Mortality was proportionally higher in the SA group, without significance 29% vs. 43% (150), p 0.09. Heart failure, septic shock and neurological deterioration conditioned mortality: HR 1.96, 1.69 and 1.37 (CI 95% 1.40–2.73; 1.19–2.39 and 0.99–1.88 respectively) and to a lesser degree SA as aetiology agent and age. Left-sided IE caused by GBS is similar in severity to left-sided IE caused by SA.
KeywordsLeft-sided infective endocarditis Streptococcus agalactiae Staphylococcus aureus
Compliance with ethical standards
All procedures followed were in accordance with the ethical standards. Informed consent was obtained from all patients for being included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Schully BE, Spriggs D, Neu H (1987) Streptococcus agalactiae (group B) endocarditis. A description of twelve cases and review of the literature. Infection 3:21–23Google Scholar
- 4.Marrón A, Carratalá J, Peña C, Roson B, Tubau F, Rufi G (1997) Endocarditis caused by group B streptococci in adults. Enferm Infecc Microbiol Clin 15:147–150Google Scholar
- 9.Ro A (2016) Streptococcus agalactiae infective endocarditis complicated by large vegetations at aortic valve cups along with intracoronary extension: an autopsy case report. Cardiovasc Pathol:221–224Google Scholar
- 10.de Chiara B, Peritore A, Sara R, Giannattasio C, Moreo A (2016) Infective endocarditis of an aortic flap due to Streptococcus agalactiae in a patient with Sjögren’s syndrome: an unusual clinical case report. Echocardiography xx:1–2Google Scholar
- 11.Ivanova Georgieva R, García López MV, Ruiz-Morales J, Martínez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, Gálvez-Aceval J, Márquez M, de Alarcón A, for the Andalusian Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases (SAEI) (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect 61:54 5927CrossRefGoogle Scholar
- 13.Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ, Reguera JM, Plata A, Ruiz J, Márquez M, Lomas JM, de la Torre-Lima J, Hidalgo-Tenorio C, de Alarcón A, Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI) (2010) Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 10:1–8CrossRefGoogle Scholar
- 15.Marín M, Muñoz P, Sanchez M, del Rosal M, Alcalá L, Rodríguez Créixems M, Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital et al (2007) Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86:195–202CrossRefGoogle Scholar
- 21.Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRefGoogle Scholar
- 25.van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin –induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antomicrob Agents Chemoter 57:733–744Google Scholar
- 26.Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L, Nadasdy T (2006) Staphylococcus infection- associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol:1179–1186Google Scholar
- 28.Fernández-Hidalgo N, Ribera A, Larrosa MN, Vedma E, Origüer J et al (2018) Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect 24(9):985–991CrossRefGoogle Scholar